Fresenius Ag [Dem 50 (FSNUF) 48.6475 $FSNUF
Research Report on Hemodialysis Industry in China, 2014-2018
M2 - Wed Sep 17, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wn2tjb/research_report) has announced the addition of the "Research Report on Hemodialysis Industry in China, 2014-2018" report to their offering. The market size of Chinese hemodialysis market exceeded CNY 20 billion in China in 2013 with the annual growth rate of 20%- 30%. Instruments, drugs and services are three major factors of the hemodialysis market, also the three entry points of the industry chain. Hemodialysis (also HD) is one of the replace therapy for patients with acute and chronic renal failure. There are globally 2.2 million uremia patients (end stage renal disease, ESRD) receiving dialysis treatment, including over 89% of them receiving hemodialysis. As the cost of hemodialysis is high, most dialysis patients are concentrated in developed regions like Europe and the U.S. The dialysis patients are fewer in developing countries but increases rapidly. In recent years, the growth rate of dialysis patients in China, India and Brazil remains above 15%, much higher than 3%- 5% in Europe and the U.S. Meanwhile, the proportion of ESRD patients that receive dialysis treatment is only 10%- 20% in developing countries, much lower than 80% in Europe and the U.S.A. By 2020, the global ESRD patients receiving hemodialysis treatment will reach 4.2 million while that in China will surpass 1 million. The market size of Chinese hemodialysis market is expected to exceed CNY 70 billion in China by 2020 with the CAGR above 20%. Meanwhile, the market size of auxiliary drugs will exceed CNY 60 billion. Key Topics Covered: 1 Overview of Hemodialysis Industry 2 Analysis of Global Hemodialysis Market, 2011-2014 3 Development Environment of China Hemodialysis Industry, 2011-2018 4 Operation Status of China Hemodialysis Industry, 2011-2014 5 Competition Status of China Hemodialysis Industry, 2011-2014 6 Analysis of Import and Export of Hemodialysis Equipment and Drugs in China, 2011-2014 7 Key Enterprises in China Hemodialysis Market, 2011-2014 8 Prospect of China Hemodialysis Industry Companies Mentioned - Asahi Kasei Corporation - Bain Medical Equipment (Guangzhou) Co., Ltd. - Baxter International - Fresenius SE & Co. KGaA - Guangdong Biolight Meditech Co., Ltd. - Huaren Pharmaceutical Co., Ltd. - Jihua Medical Apparatus and Instruments Co., Ltd. - Nipro Co.,Ltd. - Sichuan Kelun Pharmaceutical Co., Ltd. - Weigao Group For more information visit http://www.researchandmarkets.com/research/wn...rch_report
Global Dialysis Products and Services (Hemodialysis Products, Peritoneal Dialysis Products
M2 - Thu Sep 11, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c8vw2r/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market. According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market. According to the Australian Institute of Health and Welfare, the proportion of people opting for kidney transplantation decreases with age. Moreover, increasing awareness about peritoneal dialysis is expected to boost the growth of the market in the near future. The global dialysis products and services market is segmented by type of procedures and type of services. The procedures market is further segmented into hemodialysis and peritoneal dialysis. Further, the hemodialysis segment (HD) is classified into HD machine, dialyzer, access products/catheters, bloodlines, concentrates and others, which include water treatment systems and fistula needles. Hemodialysis, being the oldest and most preferred technique for dialysis procedure, Hemodialysis machines captures the largest share, of the total market in 2013. The segment is expected to lead the market during the forecast period from 2014 to 2020. Similarly, peritoneal dialysis (PD) segment is classified into concentrates/dialysate, PD machines, catheters, and transfer sets. Among these, the PD concentrates/dialysate segment is accounted for largest market share in 2013 and is expected to grow at an attractive higher growth rate during the forecast period from 2014 to 2020. The major factors responsible for the significant growth of this segment are increase in the number of patients preferring peritoneal dialysis, and rising demand of patients to be dialyzed overnight with the aid of peritoneal dialysis. Dialysis Products and Services Market, by Product type: Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/c8...s_products
DuPont appoints Ulf M. "Mark" Schneider to board
M2 - Mon Aug 04, 5:01AM CDT
Science and engineering company DuPont (NYSE
D) reported on Friday the addition of Ulf M. (Mark) Schneider to its board of directors, effective Oct. 22.
Mark Schneider Elected to DuPont Board of Directors
PR Newswire - Fri Aug 01, 3:01PM CDT
DuPont today announced the election of Ulf M. "Mark" Schneider, President and CEO of Fresenius SE & Co. KGaA to its board of directors, effective Oct. 22.
Concise Analysis of the International Enteral Feeding Devices Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/ldl6z9/enteral_feeding) has announced the addition of the "Concise Analysis of the International Enteral Feeding Devices Market" report to their offering. This report analyzes the worldwide markets for Enteral Feeding Devices in US$ Million by the following Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. The report provides separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 38 companies including many key and niche players such as: - American HomePatient, Inc. - Amsino International, Inc. - Applied Medical Technology, Inc. - Boston Scientific Corporation - C. R. Bard, Inc. - Caesarea Medical Electronics Ltd. - Cook Medical, Inc. - CONMED Corporation - CORPAK MedSystems, Inc. - Covidien Plc - Fresenius SE & Co. KGaA - Fresenius KABI AG - Kimberly-Clark Corporation - Moog Inc. - Nestl? HealthCare Nutrition - Nutricia Advanced Medical Nutrition - VYGON SA Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Trends & Issues 3. Product Overview 4. Recent Product Innovations/ Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 38 (including Divisions/Subsidiaries - 52) - The United States (24) - Canada (1) - Europe (20) - France (3) - Germany (5) - The United Kingdom (6) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (6) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/ld...al_feeding
Intravenous Solutions (Parenteral Nutrition) - 2013 Global Strategic Business Report Features Giants such as Actavis, Inc and Hospira, Inc.
M2 - Mon Sep 02, 12:17PM CDT
Research and Markets (http://www.researchandmarkets.com/research/jvnnn3/intravenous#summary) has announced the addition of the "Intravenous Solutions (Parenteral Nutrition) - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Intravenous Solutions (Parenteral Nutrition) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 30 companies including many key and niche players such as: - Actavis Inc. - B. Braun Melsungen AG - Baxter International Inc. - Claris Lifesciences Ltd. - Fresenius SE & Co. KGaA - Fresenius Kabi AG - Sino-Swed Pharmaceutical Corp. Ltd. - Hospira Inc. - Otsuka Pharmaceutical Factory Inc. - Marck Biosciences Ltd. - Sichuan Kelun Pharmaceutical Co. Ltd. - Terumo Corporation - The Galenica Group - Vifor Pharma. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered: Normal 0 false false false MicrosoftInternetExplorer4 I. Introduction, Methodology & Product Definitions Ii. Executive Summary 1. Industry Overview 2. Intravenous Solutions 3. Parenteral Nutrition - An Overview 4. Product Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective Iii. Market Iv. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/jv...us#summary About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research Report on Hemodialysis Industry in China, 2014-2018
M2 - Wed Sep 17, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wn2tjb/research_report) has announced the addition of the "Research Report on Hemodialysis Industry in China, 2014-2018" report to their offering. The market size of Chinese hemodialysis market exceeded CNY 20 billion in China in 2013 with the annual growth rate of 20%- 30%. Instruments, drugs and services are three major factors of the hemodialysis market, also the three entry points of the industry chain. Hemodialysis (also HD) is one of the replace therapy for patients with acute and chronic renal failure. There are globally 2.2 million uremia patients (end stage renal disease, ESRD) receiving dialysis treatment, including over 89% of them receiving hemodialysis. As the cost of hemodialysis is high, most dialysis patients are concentrated in developed regions like Europe and the U.S. The dialysis patients are fewer in developing countries but increases rapidly. In recent years, the growth rate of dialysis patients in China, India and Brazil remains above 15%, much higher than 3%- 5% in Europe and the U.S. Meanwhile, the proportion of ESRD patients that receive dialysis treatment is only 10%- 20% in developing countries, much lower than 80% in Europe and the U.S.A. By 2020, the global ESRD patients receiving hemodialysis treatment will reach 4.2 million while that in China will surpass 1 million. The market size of Chinese hemodialysis market is expected to exceed CNY 70 billion in China by 2020 with the CAGR above 20%. Meanwhile, the market size of auxiliary drugs will exceed CNY 60 billion. Key Topics Covered: 1 Overview of Hemodialysis Industry 2 Analysis of Global Hemodialysis Market, 2011-2014 3 Development Environment of China Hemodialysis Industry, 2011-2018 4 Operation Status of China Hemodialysis Industry, 2011-2014 5 Competition Status of China Hemodialysis Industry, 2011-2014 6 Analysis of Import and Export of Hemodialysis Equipment and Drugs in China, 2011-2014 7 Key Enterprises in China Hemodialysis Market, 2011-2014 8 Prospect of China Hemodialysis Industry Companies Mentioned - Asahi Kasei Corporation - Bain Medical Equipment (Guangzhou) Co., Ltd. - Baxter International - Fresenius SE & Co. KGaA - Guangdong Biolight Meditech Co., Ltd. - Huaren Pharmaceutical Co., Ltd. - Jihua Medical Apparatus and Instruments Co., Ltd. - Nipro Co.,Ltd. - Sichuan Kelun Pharmaceutical Co., Ltd. - Weigao Group For more information visit http://www.researchandmarkets.com/research/wn...rch_report
Global Dialysis Products and Services (Hemodialysis Products, Peritoneal Dialysis Products
M2 - Thu Sep 11, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c8vw2r/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market. According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market. According to the Australian Institute of Health and Welfare, the proportion of people opting for kidney transplantation decreases with age. Moreover, increasing awareness about peritoneal dialysis is expected to boost the growth of the market in the near future. The global dialysis products and services market is segmented by type of procedures and type of services. The procedures market is further segmented into hemodialysis and peritoneal dialysis. Further, the hemodialysis segment (HD) is classified into HD machine, dialyzer, access products/catheters, bloodlines, concentrates and others, which include water treatment systems and fistula needles. Hemodialysis, being the oldest and most preferred technique for dialysis procedure, Hemodialysis machines captures the largest share, of the total market in 2013. The segment is expected to lead the market during the forecast period from 2014 to 2020. Similarly, peritoneal dialysis (PD) segment is classified into concentrates/dialysate, PD machines, catheters, and transfer sets. Among these, the PD concentrates/dialysate segment is accounted for largest market share in 2013 and is expected to grow at an attractive higher growth rate during the forecast period from 2014 to 2020. The major factors responsible for the significant growth of this segment are increase in the number of patients preferring peritoneal dialysis, and rising demand of patients to be dialyzed overnight with the aid of peritoneal dialysis. Dialysis Products and Services Market, by Product type: Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/c8...s_products
DuPont appoints Ulf M. "Mark" Schneider to board
M2 - Mon Aug 04, 5:01AM CDT
Science and engineering company DuPont (NYSE
D) reported on Friday the addition of Ulf M. (Mark) Schneider to its board of directors, effective Oct. 22. Mark Schneider Elected to DuPont Board of Directors
PR Newswire - Fri Aug 01, 3:01PM CDT
DuPont today announced the election of Ulf M. "Mark" Schneider, President and CEO of Fresenius SE & Co. KGaA to its board of directors, effective Oct. 22.
Concise Analysis of the International Enteral Feeding Devices Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/ldl6z9/enteral_feeding) has announced the addition of the "Concise Analysis of the International Enteral Feeding Devices Market" report to their offering. This report analyzes the worldwide markets for Enteral Feeding Devices in US$ Million by the following Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. The report provides separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 38 companies including many key and niche players such as: - American HomePatient, Inc. - Amsino International, Inc. - Applied Medical Technology, Inc. - Boston Scientific Corporation - C. R. Bard, Inc. - Caesarea Medical Electronics Ltd. - Cook Medical, Inc. - CONMED Corporation - CORPAK MedSystems, Inc. - Covidien Plc - Fresenius SE & Co. KGaA - Fresenius KABI AG - Kimberly-Clark Corporation - Moog Inc. - Nestl? HealthCare Nutrition - Nutricia Advanced Medical Nutrition - VYGON SA Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Trends & Issues 3. Product Overview 4. Recent Product Innovations/ Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 38 (including Divisions/Subsidiaries - 52) - The United States (24) - Canada (1) - Europe (20) - France (3) - Germany (5) - The United Kingdom (6) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (6) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/ld...al_feeding
Intravenous Solutions (Parenteral Nutrition) - 2013 Global Strategic Business Report Features Giants such as Actavis, Inc and Hospira, Inc.
M2 - Mon Sep 02, 12:17PM CDT
Research and Markets (http://www.researchandmarkets.com/research/jvnnn3/intravenous#summary) has announced the addition of the "Intravenous Solutions (Parenteral Nutrition) - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Intravenous Solutions (Parenteral Nutrition) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 30 companies including many key and niche players such as: - Actavis Inc. - B. Braun Melsungen AG - Baxter International Inc. - Claris Lifesciences Ltd. - Fresenius SE & Co. KGaA - Fresenius Kabi AG - Sino-Swed Pharmaceutical Corp. Ltd. - Hospira Inc. - Otsuka Pharmaceutical Factory Inc. - Marck Biosciences Ltd. - Sichuan Kelun Pharmaceutical Co. Ltd. - Terumo Corporation - The Galenica Group - Vifor Pharma. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered: Normal 0 false false false MicrosoftInternetExplorer4 I. Introduction, Methodology & Product Definitions Ii. Executive Summary 1. Industry Overview 2. Intravenous Solutions 3. Parenteral Nutrition - An Overview 4. Product Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective Iii. Market Iv. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/jv...us#summary About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
